Pharmatech Associates Appoints Warren G. Baker As Chief Executive Officer

HAYWARD, Calif.--(BUSINESS WIRE)--Pharmatech Associates today announced the appointment of Warren G. Baker as chief executive officer. Baker, a 25-year medical device and healthcare technology veteran, will be responsible for driving the company's business strategy and overall performance in a period of high growth. Calvin Wong, Pharmatech's founder and original CEO, will serve the company as chairman of the advisory board.

"To strengthen Pharmatech's position as a premier global compliance consulting firm, we are making key hires in response to the needs of our customers and the global marketplace" "To strengthen Pharmatech's position as a premier global compliance consulting firm, we are making key hires in response to the needs of our customers and the global marketplace," said Calvin Wong. "Warren's extensive experience in medical devices, in biotech, and his track record as a leader of successful companies make him a perfect fit. I am delighted to have Warren on board and eager to continue our work together as we grow and provide services that improve patients' lives."

"With the strong support of our founder, Pharmatech is expanding its technical team to focus on the Pharmatech ecosystem of Validation, Product and Process Development, Regulatory and Compliance," said Warren G. Baker. "Calvin's leadership has inspired the values we hold in our company culture. I look forward to working with him and our senior management team to help our customers improve their products and processes for better drugs and therapies that result in healthier populations worldwide."

Warren G. Baker joined Pharmatech in 2012 and brings over twenty years of senior management experience spanning startup ventures and Fortune 100 companies, serving as CEO and COO in the medical device and information technology industries. He has functional expertise with QA/RA, marketing, sales, and production in international environments, including product certifications for international devices (Class II and III) through ISO (90001, 13485 and QSR), CE Mark certification, and with the FDA and Health Canada.

About Pharmatech Associates

Staffed by industry experts, Pharmatech Associates (founded in 1995) provides consulting and services to the regulated life science industry. Pharmatech's services cover four spheres of technical expertise that are necessary throughout the complete product development lifecycle: Product and Process Development, Compliance, Regulatory, and Validation. Pharmatech advises clients that range in size from startups to large multi-national corporations on projects in Asia, Europe and North America from its headquarters in the San Francisco Bay Area. www.pharmatechassociates.com

Contacts

SIPR for Pharmatech
Judy Curtis, +1 650-274-1509
[email protected] 

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

City of Hope and Canadian biotech Biovaxys Technology reported positive animal data for their COVID vaccines that could offer alternatives to mRNA.

4D is adding a trio of executives to spearhead its work in heart, eye and lung diseases as it pushes programs into and through the clinic.

Janssen has sent off its mutation-specific non-small cell lung cancer drug amivantamab to the FDA.